Scientists from UCLA's Jonsson Comprehensive Cancer Center, led by pioneering cancer researchers Drs. Dennis Slamon and Zev Wainberg, are bringing stem cell science directly to cancer patients with an exciting new clinical trial scheduled to begin in early 2014. Partially funded by the California Institute of Regenerative Medicine (CIRM), the project builds on Slamon's previous work to develop a drug that targets tumor initiating cells, that was conducted with Wainberg.
In this NBC 4 news piece, Slamon and Wainberg discuss this breakthrough research, and the powerful potential this anti-cancer drug has in potentially defeating the disease.
Last updated: 1/17/2014 10:47:52 AM